The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
Theodora A. Constantin(Hammersmith Hospital), Charlotte L. Bevan(The London College)
Cited by 24
Related Papers
Single-molecule amplification-free multiplexed detection of circulating microRNA cancer biomarkers from serum
|Nature Communications|2021|236
Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer
|Oncogene|2019|70
Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours
|Endocrine Related Cancer|2009|56